ACRS insider trading

Open-market stock trades by Aclaris Therapeutics (ACRS) executives and directors: who bought or sold, how many shares, at what price and when.

ACRS insider trades

DateInsiderRoleTradeSharesPriceValue
Apr 23, 2026Leonard Braden Michael10 percent ownerSell300,000$4.53$1.36M

Updated 2026-11-07 11:54 UTC